HbO2 Therapeutics
PrivateLast Round
IPO
Apr 26, 2022
Total Funding Raised
$6.59M
Company Overview
HbO2 Therapeutics operates in Healthcare & Life Sciences and is based in Souderton, Pennsylvania. Its latest recorded funding round was a Convertible Debt round in December 2021.
HbO2 Therapeutics is a biotechnology company that develops, manufactures, and commercializes a proprietary technology platform for oxygen-carrying solutions for human and veterinary medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HbO2 Therapeutics Comparables
Compare HbO2 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 86% | |
| OxyVita Inc. | 86% | |
| Prolong Pharmaceuticals, LLC | 84% |
For institutional investors. Book with your work email.
HbO2 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 26, 2022 | ||||
| Convertible Debt | Dec 31, 2021 | ||||
| Early Funding | Mar 13, 2015 |
For institutional investors. Book with your work email.
HbO2 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WestPark Capital, Inc. | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Monthly visitors increased 41% MoM.
- May 1, 2025
Monthly visitors grew 118% MoM, reaching 2K.
For institutional investors. Book with your work email.
HbO2 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HbO2 Therapeutics's valuation, stock price, and market status.
Is HbO2 Therapeutics a public or private company?
HbO2 Therapeutics is a private company.
What is the current stock price of HbO2 Therapeutics?
HbO2 Therapeutics is a private company, so its shares have no public market price. Caplight tracks HbO2 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HbO2 Therapeutics worth (valuation)?
Valuation information for HbO2 Therapeutics is not publicly available.
Can I buy HbO2 Therapeutics stock?
HbO2 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HbO2 Therapeutics's last funding round?
HbO2 Therapeutics's most recent funding round was IPO on April 26, 2022.
Who are the main investors in HbO2 Therapeutics?
Key investors in HbO2 Therapeutics include WestPark Capital, Inc..
Will HbO2 Therapeutics IPO soon?
No public IPO plans have been announced for HbO2 Therapeutics.
How can I track HbO2 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in HbO2 Therapeutics's shares on secondary markets.